Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of fluorinated active pharmaceutical ingredients (APIs) where stereochemistry plays a critical role in biological activity. Its structure supports the development of drugs targeting central nervous system disorders and enzyme inhibitors. The presence of bromo and fluoro substituents allows for further functionalization via cross-coupling reactions, making it valuable in medicinal chemistry for structure-activity relationship (SAR) studies. Commonly employed in asymmetric synthesis routes to ensure high enantiomeric purity in final drug compounds.